People
With our Diversity and Inclusion Survey, we’ve set out to answer this question in a multitude of areas: religion, sexual orientation, political affiliation, gender identity, and more. Plus, we want to know how you perceive the diversity and inclusiveness of the industry.
Biopharma and life sciences companies bolster their executive ranks and boards with these Movers & Shakers.
While Russian President Vladimir Putin expressed confidence in the preventative medication against the novel coronavirus, scientists from across the globe expressed concern over the lack of available data.
A recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively-impacted by COVID-19 are also the least represented in these clinical studies.
Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer.
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers and Shakers.
Although obesity is a known risk factor for death from many conditions, such as cardiovascular disease, experts are now wondering how COVID-19 may impact those who fall into this category.
A small biotech company is aiming to recharge tired cells, giving mitochondrial disease patients new hope of a disease-specific treatment.
Several polls have suggested that as much as half of the U.S. population is unlikely to get the vaccine for a variety of reasons, including not feeling it is safe.
Data security risks are growing as more and more clinical trials embrace telemedicine and other digital technologies.
PRESS RELEASES